NCT00437437View on ClinicalTrials.gov

A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

May 31, 2008

Study Completion Date

February 28, 2013

Conditions
Tumors
Interventions
DRUG

Brivanib

Tablet, Oral, Brivanib 800 mg, QD after single dose Pk comparison of food effect, until progression

Trial Locations (3)

27710

Duke University Medical Center-Dept Of Medicine, Durham

02115

Dana-Farber Harvard Cancer Care, Boston

48201-2194

Wayne State University, Detroit

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY